Karyopharm Therapeutics

KPTI

NASDAQHealth Care

Income Statement

Total Revenue$145.24M

Gross Profit$139.23M

Operating Income$-119.44M

EBITDA$-38.6M

EBIT$-38.94M

Pre-tax Income$-194.96M

Net Income$-76.42M

Cash Equivalent$63.12M

Total Debt$190.21M

Book Value$-161.69M

Book Value Per Share-20.10

Return on Equity (ROE)-388.71%

Return on Assets (ROA)-46.48%

Return on Invested Capital (ROI)-81.28%

Net Profit Margin-52.62%

Current Ratio1.70

Quick Ratio1.51

Long-Term Debt / Equity3.78